INNT
TOTAL INVALIDATION PROCESSED BY THE IB
04/26/2025
Back to search
Official data from USPTO
NOKSIPZA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
04/27/2025
Trademark type
Word
Nice classes
5, 35
Filing date
01/17/2017
Registration date
10/31/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/17/2024
Last transaction
04/27/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Gyeonggi-do, KR
Examiner
MCCRAY, RENEE
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Green Cross Holdings Corporation
Representatives
Yoon S. Ham HAUPTMAN HAM, LLP
Technical classification
Nice Classes
Class 5Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical agents affecting sensory organs; thyroid and para-thyroid hormone preparations; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; vaccines against flu; veterinary vaccines; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for the treatment of the immune system by regulating it; virucides; vaccine preparations; adrenal hormone preparations; pharmaceutical preparations for use in gynecology; pharmaceutical preparations for use in urology; vitamin tablets; pharmaceutical preparations for wounds; cellular function activating agents for medical purposes; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; veterinary substances and preparationsantioxidants; veterinary diagnostic reagents for use in veterinary genetic testing; pharmaceutical preparations for the treatment of cardiovascular disease; ophthalmic preparations; ophthalmologic preparations; eye drops; pharmaceutical preparations for treating allergies; pharmaceutical preparations for the prevention and treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical agents for epidermis; sanitary sterilising preparations; medicines for the treatment of gastrointestinal diseases; medicated mouth care and treatment preparations; parasiticides for medical use; diagnostic preparations for medical or veterinary purposes; cleansing solutions for medical use; cardiovascular agents for medical purposes; reagents for medical use; reagents for use in medical genetic testing; hemostatics for medical purposes; antibacterial substances for medical purposes; diuretics; insulin; human vaccine preparations; general anesthetics; pharmaceutical preparations for the treatment of auto-immune diseases; multivitamin preparations; pharmaceutical preparations acting on the central nervous system; styptic pencils for medical purposes; pharmaceutical preparations for treating asthma; pharmaceutical solutions used in dialysis; penicillin preparations; antimicrobials for dermatologic use; pharmaceutical preparations for treating skin disorders; contraceptive preparations; antihypertensives; anti-diabetic pharmaceuticals; antitoxins; antivirals; antiarrhythmic agents; antibiotic preparations; anti-cancer preparations; anticoagulants; tumor suppressing agents; antifungal preparations; anti-dermoinfectives; antidotes; antipyretic analgesics; vasoconstrictors; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; mixed antibiotic preparations; mixed hormone preparations; chemotherapeutics; pharmaceutical preparations for use in discouraging the smoking habitsmoking cessation preparations
Class 35
Retail and wholesale store services for pharmaceuticalveterinary and sanitary preparations and medical supplies; advertising services relating to pharmaceutical products; advertising relating to pharmaceutical products and in-vivo imaging products
Publications
History of USPTO decisions and trademark events.
34 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
04/08/2025
INPC
INVALIDATION PROCESSED
04/08/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
01/18/2025
C71T
CANCELLED SECTION 71
05/17/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/31/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/13/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/12/2018
FIMP
FINAL DISPOSITION PROCESSED
02/12/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/31/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
10/31/2017
GPNX
NOTIFICATION PROCESSED BY IB
08/18/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/15/2017
PUBO
PUBLISHED FOR OPPOSITION
08/15/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/02/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/02/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/26/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/10/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/06/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/05/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/05/2017
ALIE
ASSIGNED TO LIE
06/29/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/01/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/31/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/31/2017
RFNT
REFUSAL PROCESSED BY IB
05/05/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/19/2017
RFRR
REFUSAL PROCESSED BY MPU
04/19/2017
MAFR
APPLICATION FILING RECEIPT MAILED
04/18/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/16/2017
CNRT
NON-FINAL ACTION WRITTEN
04/15/2017
DOCK
ASSIGNED TO EXAMINER
04/15/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/14/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/13/2017
Continuous trademark protection
Get notified about every new filing that threatens NOKSIPZA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.